[ad_1]
Adults with Type-2 diabetes now have a new medication to discuss with their doctors.
The Food and Drug Administration has granted Eli Lilly and Co. approval for Mounjaro (tirzepatide), an injection that can improve blood sugar control.
Type 2 diabetes is the most common type with more than 30-million Americans diagnosed. It can be a progressive condition with the patient’s body unable to ma…
[ad_2]
Source link
